Listen "Ep001 - Graeme Duncan - Neurocentrx Pharma"
Episode Synopsis
In this episode we discuss how Neurocentrx Pharma are leading the way in developing an oral Ketamine capsule for the treatment of mood disorders.***This podcast must not be taken as medical advice. If you are seeking treatment or would like to participate in a clinical trial, please speak to your doctor, GP or primary physician in the first instance***Graeme Duncan is Head of Clinical Development at Neurocentrx Pharma.https://www.neurocentrx.com/This podcast is sponsored by leading clinical development company Caritas Science Solutions https://caritasscience.co.uk/And hosted by Leigh Fellhttps://www.leighfell.com/Edited by Callum Greens - Wolfie Mediahttps://calzo.uk
More episodes of the podcast The Leading Life Science Podcast
S3. Ep002 Some thoughts on Ozempic
29/01/2025
S3. Ep001 JP Morgan - AI Buzz
29/01/2025
S.02-Ep002 - Roslin CT
29/08/2024
S.02-Ep001 - Dr David R Hamilton
17/05/2024
Ep006 - David Mulligan, CEO of Funding Neuro
28/02/2024